Recently, Dr. Zigang Li/Dr. Feng Yin's research group from Pingshan Center cooperated with Dr. Yaoqi Zhou's research group from Shenzhen Bay Laboratory to develop a novel polypeptide-drug conjugate targeting the papain-like protease (PLpro) protein of the new coronavirus (SARS-CoV-2). The results were published in the Journal of Medicinal Chemistry with the title of "Design and Evaluation of a Novel Peptide-Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-Like Protease (PLpro)".